Structures by: Lou K. X.
Total: 5
C12H9ClFNO3
C12H9ClFNO3
Acta Crystallographica Section E (2004) 60, 5 o824-o825
a=7.145(3)Å b=8.915(4)Å c=9.375(4)Å
α=71.896(6)° β=80.025(7)° γ=85.109(7)°
C9H16N2O2S
C9H16N2O2S
Acta Crystallographica Section E (2003) 59, 9 o1290-o1292
a=7.018(6)Å b=8.818(7)Å c=18.760(16)Å
α=90.00° β=90.00° γ=90.00°
3-Chloro-N-(7-fluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl)- 2,2-dimethylpropionamide
C16H16ClFN2O3
Acta Crystallographica Section E (2004) 60, 10 o1788-o1789
a=13.292(4)Å b=7.529(2)Å c=17.213(5)Å
α=90.00° β=111.607(5)° γ=90.00°
Levetiracetam
C8H14N2O2
Acta Crystallographica Section E (2003) 59, 11 o1772-o1773
a=6.272(5)Å b=7.993(5)Å c=9.199(7)Å
α=90.00° β=108.645(9)° γ=90.00°
7-Chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid
C13H9ClFNO3
Acta Crystallographica Section E (2004) 60, 4 o503-o504
a=9.194(4)Å b=7.515(4)Å c=16.635(8)Å
α=90.00° β=93.784(7)° γ=90.00°